Showing results (111-120 of 179) with videos related to
Sort By:
Pageof 18
The Oncologist|May 18, 2018
Phase II Study of Irinotecan Plus Panitumumab as Second-Line Therapy for Patients with Advanced Esophageal AdenocarcinomaHarry Yoon, Lilit Karapetyan, Anita Choudhary, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancerDavid J Adelstein, Yi Li, George L Adams, et al.The American Journal of Surgical Pathology|October 15, 2005
Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implicationsEric L Powell, Lorenzo M Leoni, Marcia I Canto, et al.The Laryngoscope|May 27, 2015
Quality of care and short- and long-term outcomes of laryngeal cancer care in the elderlyChristine G Gourin, Heather M Starmer, Robert J Herbert, et al.The Laryngoscope|January 17, 2014
Quality indicators of laryngeal cancer care in the elderlyChristine G Gourin, Kevin D Frick, Amanda L Blackford, et al.Cancer|April 13, 2000
Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patientsA Chak, M I Canto, G S Cooper, et al.The Laryngoscope|February 12, 2014
Treatment, survival, and costs of laryngeal cancer care in the elderlyChristine G Gourin, Sydney M Dy, Robert J Herbert, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicityM P Goren, A A Forastiere, R K Wright, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagusD H Ilson, J Ajani, K Bhalla, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 12, 2009
Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancerB Burtness, M Gibson, B Egleston, et al.Pageof 18